BA
The Boeing Company
BA has the edge over HNI overall, supported by stronger valuation and stronger fundamentals.
HNI
HNI Corporation
HNI's outlook is improving despite an expensive valuation.
BA Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Stable | |
| Under pressure |
BA's profitability is currently healthy, and its revenue and cash flow are stable, but its balance sheet is under pressure.
HNI Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Stable | |
| Stable | |
| Under pressure |
HNI's revenue is currently strong, and its profitability and cash flow are stable, but its balance sheet is under pressure.
BA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 18x | $172 | — |
| Cheap | 51x | $496 | +189% |
| Fair | 82x | $790 | +360% |
| Expensive | 91x | $876 | +411% |
Historical ranges are pointers, not guarantees.
BA has the edge over HNI in the historical PE scenario, which offers more potential upside but is not a forecast.
HNI PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 11x | $48.20 | — |
| Cheap | 14x | $4.07 | -92% |
| Fair | 20x | $5.92 | -88% |
| Expensive | 32x | $9.54 | -80% |
| Current | 161x | $48.20 | — |
Historical ranges are pointers, not guarantees.
HNI's PE is in its expensive range at 161x. If earnings grow as analysts expect, today's price would be 11x next year's earnings, in its cheap range.
BA Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Returning to profit | |
| Growth | |
| Improving | |
| Limited | |
| Low |
BA has the edge over HNI on the outlook, with more favorable profitability expectations.
HNI Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Growth | |
| Stable | |
| Limited | |
| High |
Analysts expect earnings and revenue growth for HNI, with profitability holding steady.
BA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $9.66 | +$23.38 |
| Q2 2026 | $2.78 | +$19.33 |
| Q1 2026 | $2.53 | +$20.49 |
| Q4 2025 | $2.48 | +$20.84 |
| Q3 2025 | -$13.72 | -$0.83 |
| Q2 2025 | -$16.55 | -$10.93 |
| Q1 2025 | -$17.96 | -$14.42 |
| Q4 2024 | -$18.36 | -$14.69 |
BA has returned to profit: it earned $9.66 per share over the past year, after losing money the year before.
HNI Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.41 | +1369% |
| Q3 2026 | $0.30 | -90% |
| Q2 2026 | -$0.05 | -102% |
| Q1 2026 | $0.27 | -90% |
| Q4 2025 | $1.11 | -61% |
| Q3 2025 | $2.97 | +12% |
| Q2 2025 | $3.07 | +24% |
| Q1 2025 | $2.80 | +97% |
| Q4 2024 | $2.88 | +164% |
HNI's earnings per share have fallen from their peak: $0.30 over the past year, against $3.07 in mid-2025.
BA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $24.2B | +3.9% |
| Q2 2026 | $24.6B | +8% |
| Q1 2026 | $22.2B | +14% |
| Q4 2025 | $23.9B | +57% |
| Q3 2025 | $23.3B | +30% |
| Q2 2025 | $22.7B | +35% |
| Q1 2025 | $19.5B | +18% |
| Q4 2024 | $15.2B | -31% |
BA's revenue has grown year over year for seven quarters in a row: $24.2B last quarter, up 3.9% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 1.5% | +22 points |
| Q2 2026 | 0.6% | +1.4 points |
| Q1 2026 | 2% | -0.3 points |
| Q4 2025 | 37% | +61 points |
| Q3 2025 | -21% | +12 points |
| Q2 2025 | -0.8% | +5.7 points |
| Q1 2025 | 2.4% | +2.9 points |
| Q4 2024 | -25% | -26 points |
BA's operating margin was 1.5% last quarter, up 22 points from the same quarter a year ago.
HNI Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $1.6B | +133% |
| Q2 2026 | $1.5B | +121% |
| Q1 2026 | $1.3B | +125% |
| Q4 2025 | $888.4M | +38% |
| Q3 2025 | $683.8M | +1.7% |
| Q2 2025 | $667.1M | +7% |
| Q1 2025 | $599.8M | +2% |
| Q4 2024 | $642.5M | -5.5% |
HNI has the edge over BA on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 8.6% | -0.9 points |
| Q2 2026 | 6.3% | -4 points |
| Q1 2026 | -2.7% | -6.8 points |
| Q4 2025 | -3.5% | -12 points |
| Q3 2025 | 9.4% | -0.8 points |
| Q2 2025 | 10% | +1.7 points |
| Q1 2025 | 4.1% | -1 points |
| Q4 2024 | 8.5% | +4 points |
HNI has the edge over BA on profitability, with a higher operating margin.
BA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $464M | +95% |
| Q2 2026 | $631M | +$831M |
| Q1 2026 | -$1.5B | +$836M |
| Q4 2025 | $375M | +$4.5B |
| Q3 2025 | $238M | +$2.2B |
| Q2 2025 | -$200M | +$4.1B |
| Q1 2025 | -$2.3B | +$1.6B |
| Q4 2024 | -$4.1B | -239% |
BA has the edge over HNI on cash flow, with more consistent year-over-year improvement.
HNI Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $195.3M | +44% |
| Q2 2026 | $139.8M | +768% |
| Q1 2026 | -$207.5M | -$203.8M |
| Q4 2025 | $60.4M | +46% |
| Q3 2025 | $135.6M | +19% |
| Q2 2025 | $16.1M | -52% |
| Q1 2025 | -$3.7M | +$11.8M |
| Q4 2024 | $41.5M | -53% |
HNI generated $188M in free cash flow over the past year, about the same as the year before.
BA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.3% | +2.1M shares |
| 1 year | +4.3% | +32.8M shares |
| 3 years | +31% | +186M shares |
| 5 years | +35% | +204M shares |
| Available history | +40% | +227M shares |
BA has the edge over HNI on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2019 | — |
HNI Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.6% | +400K shares |
| 1 year | +54% | +25.4M shares |
| 3 years | +67% | +29.2M shares |
| 5 years | +63% | +28M shares |
| Available history | +67% | +29M shares |
HNI has 73M diluted shares, up 54% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | $5.6M |
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | $3.8M |
| Q2 2025 | $39.4M |
| Q1 2025 | $40.4M |
| Q4 2024 | $41M |
HNI spent $6M buying back its own shares over the past year, down 96% from the year before.
BA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 3.0x | Elevated |
| Q2 2026 | 5.7x | High |
| Q1 2026 | 6.0x | High |
| Q4 2025 | 6.9x | High |
| Q2 2024 | 361.8x | High |
| Q1 2024 | 36.1x | High |
| Q4 2023 | 36.4x | High |
| Q3 2023 | 96.1x | High |
BA's net debt is about 3.0 years of its operating earnings (EBITDA), down from more than 20 years a year ago.
HNI Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 3.1x | Elevated |
| Q2 2026 | 4.4x | High |
| Q1 2026 | 6.2x | High |
| Q4 2025 | 4.7x | High |
| Q3 2025 | 1.0x | Very low |
| Q2 2025 | 1.3x | Healthy |
| Q1 2025 | 1.2x | Healthy |
| Q4 2024 | 1.0x | Healthy |
HNI's net debt is about 3.1 years of its operating earnings (EBITDA), up from a year a year ago.
BA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 31.1 | Neutral |
| Stochastic | 9.6 | Oversold |
BA's weekly RSI is 31 (neutral) and its Stochastic is 10 (oversold).
HNI Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 59.5 | Neutral |
| Stochastic | 57.2 | Neutral |
HNI's weekly RSI is 60 (neutral) and its Stochastic is 57 (neutral).
BA PE vs Industrials Sector
| Metric | BA | Sector median | Relative |
|---|---|---|---|
| PE | 18x | 24x | 26% below |
| PE % | 0 | 58 | 58 pts below |
BA has the edge over HNI on valuation relative to its sector.
HNI PE vs Industrials Sector
| Metric | HNI | Sector median | Relative |
|---|---|---|---|
| PE | 161x | 24x | 568% above |
| PE % | 100 | 58 | 42 pts above |
HNI is trading at 161x earnings, a 568% premium to the Industrials sector's median of 24x.
BA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $184.6 | 7.1% below |
| 20 week MA | $203.8 | 16% below |
| 50 week MA | $215.5 | 20% below |
| 100 week MA | $205.9 | 17% below |
| 200 week MA | $200.6 | 14% below |
BA is in a downtrend: it's below all five of its weekly moving averages, and 14% below its 200-week average.
HNI Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $47.5 | 1.5% above |
| 20 week MA | $46.5 | 3.8% above |
| 50 week MA | $42.4 | 14% above |
| 100 week MA | $44.2 | 9% above |
| 200 week MA | $41.9 | 15% above |
HNI has the edge over BA on trend strength, trading above more of its moving averages.
BA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $330.1 | $217.2 | -34% |
| 2021 | $217.2 | $204.2 | -6% |
| 2022 | $204.2 | $189.1 | -7.4% |
| 2023 | $189.1 | $260.7 | +38% |
| 2024 | $260.7 | $180.7 | -31% |
| 2025 | $180.7 | $216.4 | +20% |
| 2026 YTD | $216.4 | $171.6 | -21% |
BA has finished lower in four of the last six years. It's down 21% so far in 2026.
HNI Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $37.4 | $35.8 | -4.1% |
| 2021 | $35.8 | $41.1 | +15% |
| 2022 | $41.1 | $28.2 | -32% |
| 2023 | $28.2 | $41.8 | +49% |
| 2024 | $41.8 | $50.9 | +22% |
| 2025 | $50.9 | $42.3 | -17% |
| 2026 YTD | $42.3 | $48.2 | +14% |
HNI has the edge over BA on returns for 2026, with the stronger performance.